July 11 Drug distributor Alliance Pharma
said it now expects bladder cancer drug ImmuCyst,
manufactured by Sanofi SA's vaccines unit, to become
available in the second half of 2014.
Alliance Pharma told Reuters last week that it expected to
start selling the drug in the first half of 2014.
Production of ImmuCyst was suspended in mid-2012 after mould
was found in Sanofi Pasteur's 100-year-old manufacturing plant
in Toronto, Canada.
Alliance Pharma, which acquires, markets and distributes
pharmaceutical products, said that turnover in the six months
ended June 30 rose 4 percent to 22.8 million pounds ($34.07